arrow
R

Ravindra L. Mehta

university of california-san diego
H指数:89
被引数:5.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy (2023-2024)

阿拉巴马大学伯明翰分校连续肾脏替代疗法学院会议录(2023-2024)

2025-10-011
PRE
Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup

妊娠相关急性肾损伤——第32届急性疾病质量倡议工作组共识报告

2025-07-180
PREAI
Renal replacement therapy modalities and techniques in intensive care units: An international survey

重症监护室中的肾脏替代治疗模式和技巧:一项国际调查

2025-05-230
OAAI
Renin Angiotensin Inhibition and Lower Risk of Kidney Failure in Patients with Heart Failure

肾素-血管紧张素抑制与心力衰竭患者肾衰竭低风险

2025-05-070
PRE
Influence of Baseline Kidney Function on Patient and Kidney Outcomes in Patients with COVID-19: A Multi-National Observational Study

新型冠状病毒肺炎患者基线肾功能对患者和肾脏结局的影响: 一项多国观察性研究

2025-02-120
OAAI
Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement
2024-08-080
OAAI
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting

肝硬化患者急性肾损伤:急性疾病质量倡议(ADQI)与国际腹水俱乐部(ICA)联合多学科共识会议

2024-07-0118
OAAI
Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million US Veterans with heart failure
2024-05-031
PRE
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials
2024-03-217
OAAI
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)
2024-03-040
OAAI
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

重组人碱性磷酸酶治疗脓毒症相关急性肾损伤 (REVIVAL) 的3期临床试验

2024-01-0317
OAAI